Cargando…

Genomic profiling of ovarian clear cell carcinoma in Chinese patients reveals potential prognostic biomarkers for survival

INTRODUCTION: Ovarian clear cell carcinoma (OCCC) has distinct clinical and molecular features and heterogeneous prognosis. Insights into the somatic genomic abnormalities of OCCC provide the basis for deeper understanding and potential therapeutic avenues. Herein, we performed extensive genomic pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Shuang, Zhou, Shuling, Wu, Yutuan, Pei, Xuan, Jiang, Wei, Shi, Wanling, Yang, Wentao, Zhou, Xiaoyan, Shan, Boer, Yang, Huijuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243386/ https://www.ncbi.nlm.nih.gov/pubmed/37272300 http://dx.doi.org/10.1080/07853890.2023.2218104

Ejemplares similares

Integrative genomic and transcriptomic analysis reveals immune subtypes and prognostic markers in ovarian clear cell carcinoma
por: Ye, Shuang, et al.
Publicado: (2022)

The frequency and clinical implication of mismatch repair protein deficiency in Chinese patients with ovarian clear cell carcinoma
por: Ye, Shuang, et al.
Publicado: (2022)

Fibrinogen/albumin ratio as a promising predictor of platinum response and survival in ovarian clear cell carcinoma
por: Chen, Wei, et al.
Publicado: (2022)

Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications
por: Chen, Wei, et al.
Publicado: (2020)

Recurrence Patterns and Survival Outcomes in Chinese Patients with Surgically Treated Recurrent Ovarian Clear Cell Carcinoma: A Single Institutional Analysis of 45 Cases
por: Ye, Shuang, et al.
Publicado: (2020)

Changes in peripheral lymphocyte populations in patients with advanced/recurrent ovarian cancer undergoing splenectomy during cytoreductive surgery
por: Chen, Wei, et al.
Publicado: (2021)

Establishment and molecular characterization of a human ovarian clear cell carcinoma cell line (FDOV1)
por: Jiang, Wei, et al.
Publicado: (2018)

The role of [Formula: see text] F-FDG PET/CT-based quantitative metabolic parameters in patients with ovarian clear cell carcinoma
por: Ye, Shuang, et al.
Publicado: (2020)

Clinical significance of peripheral blood and tumor tissue lymphocyte subsets in cervical cancer patients
por: Wu, Yutuan, et al.
Publicado: (2020)

(18)F-FDG PET/CT-based metabolic metrics in recurrent tumors of ovarian clear cell carcinoma and their prognostic implications
por: Ye, Shuang, et al.
Publicado: (2019)

Peripheral lymphocyte populations in ovarian cancer patients and correlations with clinicopathological features
por: Ye, Shuang, et al.
Publicado: (2022)

A NOTCH1 Mutation Found in a Newly Established Ovarian Cancer Cell Line (FDOVL) Promotes Lymph Node Metastasis in Ovarian Cancer
por: Jiang, Wei, et al.
Publicado: (2023)

Prognostic Factors and Survival of Chinese Patients with Cardiac Amyloidosis
por: Zhang, Lu, et al.
Publicado: (2023)

HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer
por: Li, Anqi, et al.
Publicado: (2016)

Prognostic nomogram that predicts progression-free survival and overall survival of patients with ovarian clear cell carcinoma
por: Li, Jiayi, et al.
Publicado: (2022)

Correction: HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer
por: Li, Anqi, et al.
Publicado: (2017)

Preoperative serum microRNAs as potential prognostic biomarkers in ovarian clear cell carcinoma
por: Suzuki, Kazuhiro, et al.
Publicado: (2022)

C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma
por: Yao, Wentao, et al.
Publicado: (2023)

Endometriosis is the independent prognostic factor for survival in Chinese patients with epithelial ovarian carcinoma
por: Ren, Tong, et al.
Publicado: (2017)

Prognostic significance and predictors of the system inflammation score in ovarian clear cell carcinoma
por: Zhang, Hongwei, et al.
Publicado: (2017)

LncRNA ZFAS1 serves as a prognostic biomarker to predict the survival of patients with ovarian cancer
por: Han, Shuang, et al.
Publicado: (2019)

Mismatch repair deficiency is associated with specific morphologic features and frequent loss of ARID1A expression in ovarian clear cell carcinoma
por: Ge, Huijuan, et al.
Publicado: (2021)

Characteristic and Prognostic Implication of Venous Thromboembolism in Ovarian Clear Cell Carcinoma: A 12-Year Retrospective Study
por: Ye, Shuang, et al.
Publicado: (2015)

A clinicopathological study and survival analysis of 99 breast cancers with HER2/CEP17 ratio ≥ 2.0 and an average HER2 copy number < 4.0 per cell in China
por: Zhou, Shuling, et al.
Publicado: (2023)

Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma
por: Itamochi, Hiroaki, et al.
Publicado: (2017)

Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry
por: Engqvist, Hanna, et al.
Publicado: (2020)

Low frequency of BRAF and KRAS mutations in Chinese patients with low-grade serous carcinoma of the ovary
por: Xu, Yan, et al.
Publicado: (2017)

STK4 is a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma
por: Bai, Zi-Yuan, et al.
Publicado: (2023)

Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma
por: Weaver, Chaston, et al.
Publicado: (2022)

Development and external validation of nomograms for predicting individual survival in patients with ovarian clear cell carcinoma
por: Liu, Xiaoshi, et al.
Publicado: (2023)

Immune-related long non-coding RNAs can serve as prognostic biomarkers for clear cell renal cell carcinoma
por: Li, Cheng Shan, et al.
Publicado: (2021)

Mathematical Prognostic Biomarker Models for Treatment Response and Survival in Epithelial Ovarian Cancer
por: Nikas, Jason B., et al.
Publicado: (2011)

Prognostic Impact of ABO Blood Group on the Survival in Patients with Ovarian Cancer
por: Zhou, Juan, et al.
Publicado: (2015)

Efficacy and Prognostic Factors for PARP Inhibitors in Patients With Ovarian Cancer
por: Huang, Xuan-zhang, et al.
Publicado: (2020)

Aspirin use correlates with survival in women with clear cell ovarian cancer
por: Wield, Alyssa M., et al.
Publicado: (2018)

Ecto-5′-nucleotidase (CD73) is a biomarker for clear cell renal carcinoma stem-like cells
por: Song, Lei, et al.
Publicado: (2017)

Adipophilin as prognostic biomarker in clear cell renal cell carcinoma
por: Tolkach, Yuri, et al.
Publicado: (2017)

RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma
por: Liu, Yuenan, et al.
Publicado: (2019)

The Prognostic Value of Programmed Death-Ligand 1 in a Chinese Cohort With Clear Cell Renal Cell Carcinoma
por: Xiao, Wen-jun, et al.
Publicado: (2019)

Quantitative Assessment and Prognostic Associations of the Immune Landscape in Ovarian Clear Cell Carcinoma
por: Khalique, Saira, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9gs9f8on2ead86lj67vfsle4s7